ALPHA TRIBE

Aurobindo Pharma LimitedUpdates, 18-12-2025: General Updates

18-12-2025 | 10:05 am

Aurobindo Pharma's subsidiary, APL Healthcare, faced a US FDA inspection at its Unit-IV. A Form 483 with 5 procedural observations was issued. The company confirms no impact on facility financials or operations.

No comments yet. Be the first to comment!

All announcements from Aurobindo Pharma Limited